Comparison of the effect of Tamsulosin and Placebo on prevention of urinary retention after Herniorrhaphy, Varicocelectomy, and Anorectal Surgery.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181006041252N12

Enrollment

150

Registered

2019-06-18

Start date

2019-01-21

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary retention. Urinary calculus, unspecified

Interventions

Intervention 1: Intervention group: Patients in this group receive 3 doses of Tamsulosin capsule 0.4 mg (2 doses prior to surgery 12 hours apart and one dose 6 hours after surgery) orally. Interventio

Eligibility

Sex/Gender

All

Age

No minimum to 50 Years

Inclusion criteria

Inclusion criteria: Patients under the age of 50 years Patients undergoing urology or general surgery

Exclusion criteria

Exclusion criteria: Patients with the symptoms of urinary tract infection before surgery Patients with history of urinary retention Patients with a history of neurological disease Patients with a history of pelvic surgery Patients with a history of using Benzodiazepine, beta-agonist and alpha-agonist prior to surgery

Design outcomes

Primary

Measure	Time frame
Determine urinary retention. Timepoint: At the beginning of the study (before the intervention) and 24 hours after the intervention. Method of measurement: Measuring urine volume in 24 hours (less than 200 cc).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hamidreza Baghani

Sabzevar University of Medical Sciences

Hamid.Baghani@yahoo.com+98 51 4401 8378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026